KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biogen (BIIB) Shares Repurchased (2016 - 2022)

Biogen (BIIB) has 14 years of Shares Repurchased data on record, last reported at $250.0 million in Q3 2022.

  • For Q3 2022, Shares Repurchased fell 66.67% year-over-year to $250.0 million; the TTM value through Dec 2023 reached $250.0 million, down 66.67%, while the annual FY2022 figure was $750.0 million, 58.33% down from the prior year.
  • Shares Repurchased reached $250.0 million in Q3 2022 per BIIB's latest filing, down from $500.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $2.8 billion in Q2 2020 and bottomed at $250.0 million in Q1 2018.
  • Average Shares Repurchased over 5 years is $1.2 billion, with a median of $750.0 million recorded in 2021.
  • Peak YoY movement for Shares Repurchased: surged 251.75% in 2018, then plummeted 83.98% in 2021.
  • A 5-year view of Shares Repurchased shows it stood at $1.4 billion in 2018, then soared by 54.75% to $2.1 billion in 2019, then tumbled by 80.89% to $400.0 million in 2020, then soared by 87.5% to $750.0 million in 2021, then tumbled by 66.67% to $250.0 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $250.0 million in Q3 2022, $500.0 million in Q2 2022, and $750.0 million in Q3 2021.